Evidence map›Paper›PMID 28813624›Full record

ArticleRadiation research2017

TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive Response.

Jeffrey S Murley, Richard C Miller, Ralph R Weichselbaum, David J Grdina

Open access · greenAbstract read
In one paragraph

Article in Radiation research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Role of p53 in Regulating Radiation Responses.Life (Basel, Switzerland) · 2022
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeffrey S MurleyDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois 60637.
Richard C MillerDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois 60637.
Ralph R WeichselbaumDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois 60637.
David J GrdinaDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois 60637.
University of Chicago · US

Funding

Radiation Protectors and Radiation Therapy Coupled ChemopreventionR01CA132998 · NCI · UNIVERSITY OF CHICAGO · PI GRDINA, DAVID J. · 2009 to 2013
$1.6M
NCI NIH HHS R01 CA132998
6 · The paper itself

Abstract

A survivin-associated radio-adaptive response, characterized by increased radiation resistance or sensitization, was induced by exposure to 5 mGy of ionizing radiation and was correlated to the TP53 mutational status of exposed cells. Ten human cancer lines were investigated: colorectal carcinomas HCT116 and RKO [TP53 wild-type (WT)] and their respective TP53 null isogenic lines; breast adenocarcinomas MCF7 (TP53 WT) and MDA-MB-231 (TP53 Mut); lung carcinomas A549 (TP53 WT) and NCI-H1975 (TP53 Mut); and pancreatic carcinomas Hs766T (TP53 WT) and Panc-1 (TP53 Mut). Radiation induced (5 mGy) changes in the subsequent responses to 2 Gy in a multi-dose paradigm. Effects on radiation sensitivity were associated with changes in survivin's intracellular translocation to the cytoplasm (TP53 WT) or nucleus (TP53 Mut). Survival responses were determined using a colony forming assay. Intracellular localization of survivin was determined by ELISA and correlated with survival response. Two 2 Gy doses had minimal effects on the intracellular translocation of survivin. When preceded 15 min earlier by a 5 mGy exposure, survivin translocated to the cytoplasm in all of the TP53 WT cell lines, and to the nuclei in the TP53 null and Mut cells. All TP53 WT cells were protected (P < 0.001) by 5 mGy exposures, while Mut cells were sensitized (P < 0.001). HCT116 and RKO TP53 WT cells were admixed with their respective isogenic TP53 null counterparts in different proportions: 75% to 25%, 50% to 50% and 25% to 75%, respectively. All mixed confluent cultures expressed enhanced radio-sensitization (P ≤ 0.047) characteristic of TP53 Mut cells, which could be inhibited by their exposure to the antioxidant N-acetyl-l-cysteine (NAC) indicating a role for intercellular signaling by reactive oxygen species (ROS). ROS signaling in propagating the survivin-mediated response is involved in both intra- and intercellular communication processes.

Indexed as

AcetylcysteineDose-Response Relationship, RadiationGene Expression RegulationGenomicsHCT116 CellsHumansInhibitor of Apoptosis ProteinsMutationRadiation ToleranceReactive Oxygen SpeciesSurvivinTumor Suppressor Protein p53AcetylcysteineBIRC5 protein, humanInhibitor of Apoptosis ProteinsReactive Oxygen SpeciesSurvivinTumor Suppressor Protein p53

Identifiers

PMID28813624
PMCPMC5705057
OpenAlexW2749000912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.